Selected research
Market Structure
Global Medicated Confectionery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medicated Confectionery market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medicated Confectionery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medicated Confectionery include Perfetti Van Melle (Halls), Reckitt Benckiser (Strepsils), Ricola AG, Jakemans, Wrigley Company, Mondelez International (Ernest Jackson), Nestle, Procter & Gamble and Meda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medicated Confectionery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medicated Confectionery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medicated Confectionery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medicated Confectionery market size, projected growth trends, production technologies, key applications, and end-use industries.
Medicated Confectionery Segment by Company
Perfetti Van Melle (Halls)
Reckitt Benckiser (Strepsils)
Ricola AG
Jakemans
Wrigley Company
Mondelez International (Ernest Jackson)
Nestle
Procter & Gamble
Meda Pharmaceuticals
UHA Mikakuto
Herbion International
HEXOS
Lofthouse of Fleetwood
Läkerol
Luden's
Olbas
Baker Perkins Limited
Medicated Confectionery Segment by Type
Lozenges
Chewable Tablets
Gummy
Other
Medicated Confectionery Segment by Application
Pharmacies/Drugstores
Supermarkets/Convenience Stores
Health & Wellness Stores
Hospital/Clinic Pharmacies
Online Retailers
Medicated Confectionery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Confectionery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicated Confectionery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Confectionery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medicated Confectionery market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medicated Confectionery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medicated Confectionery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medicated Confectionery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Lozenges
- Chewable Tablets
- Gummy
- Other
Applications
- Pharmacies/Drugstores
- Supermarkets/Convenience Stores
- Health & Wellness Stores
- Hospital/Clinic Pharmacies
- Online Retailers
Companies covered
- Perfetti Van Melle (Halls)
- Reckitt Benckiser (Strepsils)
- Ricola AG
- Jakemans
- Wrigley Company
- Mondelez International (Ernest Jackson)
- Nestle
- Procter & Gamble
- Meda Pharmaceuticals
- UHA Mikakuto
- Herbion International
- HEXOS
- Lofthouse of Fleetwood
- Läkerol
- Luden's
- Olbas
- Baker Perkins Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medicated Confectionery Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medicated Confectionery Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medicated Confectionery Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medicated Confectionery Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medicated Confectionery Market Dynamics
- 2.1 Medicated Confectionery Industry Trends
- 2.2 Medicated Confectionery Industry Drivers
- 2.3 Medicated Confectionery Industry Opportunities and Challenges
- 2.4 Medicated Confectionery Industry Restraints
3 Medicated Confectionery Market by Manufacturers
- 3.1 Global Medicated Confectionery Revenue by Manufacturers (2021-2026)
- 3.2 Global Medicated Confectionery Sales by Manufacturers (2021-2026)
- 3.3 Global Medicated Confectionery Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medicated Confectionery Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medicated Confectionery Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medicated Confectionery Manufacturers, Product Type & Application
- 3.7 Global Medicated Confectionery Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medicated Confectionery Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medicated Confectionery Players Market Share by Revenue in 2025
- 3.8.3 2025 Medicated Confectionery Tier 1, Tier 2, and Tier 3
4 Medicated Confectionery Market by Type
- 4.1 Medicated Confectionery Type Introduction
- 4.1.1 Lozenges
- 4.1.2 Chewable Tablets
- 4.1.3 Gummy
- 4.1.4 Other
- 4.2 Global Medicated Confectionery Sales by Type
- 4.2.1 Global Medicated Confectionery Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medicated Confectionery Sales by Type (2021-2032)
- 4.2.3 Global Medicated Confectionery Sales Market Share by Type (2021-2032)
- 4.3 Global Medicated Confectionery Revenue by Type
- 4.3.1 Global Medicated Confectionery Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medicated Confectionery Revenue by Type (2021-2032)
- 4.3.3 Global Medicated Confectionery Revenue Market Share by Type (2021-2032)
5 Medicated Confectionery Market by Application
- 5.1 Medicated Confectionery Application Introduction
- 5.1.1 Pharmacies/Drugstores
- 5.1.2 Supermarkets/Convenience Stores
- 5.1.3 Health & Wellness Stores
- 5.1.4 Hospital/Clinic Pharmacies
- 5.1.5 Online Retailers
- 5.2 Global Medicated Confectionery Sales by Application
- 5.2.1 Global Medicated Confectionery Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medicated Confectionery Sales by Application (2021-2032)
- 5.2.3 Global Medicated Confectionery Sales Market Share by Application (2021-2032)
- 5.3 Global Medicated Confectionery Revenue by Application
- 5.3.1 Global Medicated Confectionery Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medicated Confectionery Revenue by Application (2021-2032)
- 5.3.3 Global Medicated Confectionery Revenue Market Share by Application (2021-2032)
6 Global Medicated Confectionery Sales by Region
- 6.1 Global Medicated Confectionery Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medicated Confectionery Sales by Region (2021-2032)
- 6.2.1 Global Medicated Confectionery Sales by Region (2021-2026)
- 6.2.2 Global Medicated Confectionery Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medicated Confectionery Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medicated Confectionery Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medicated Confectionery Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medicated Confectionery Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medicated Confectionery Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medicated Confectionery Revenue by Region
- 7.1 Global Medicated Confectionery Revenue by Region
- 7.1.1 Global Medicated Confectionery Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medicated Confectionery Revenue by Region (2021-2026)
- 7.1.3 Global Medicated Confectionery Revenue by Region (2027-2032)
- 7.1.4 Global Medicated Confectionery Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medicated Confectionery Revenue (2021-2032)
- 7.2.2 North America Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medicated Confectionery Revenue (2021-2032)
- 7.3.2 Europe Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medicated Confectionery Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medicated Confectionery Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medicated Confectionery Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Perfetti Van Melle (Halls)
- 8.1.1 Perfetti Van Melle (Halls) Company Information
- 8.1.2 Perfetti Van Melle (Halls) Business Overview
- 8.1.3 Perfetti Van Melle (Halls) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Perfetti Van Melle (Halls) Medicated Confectionery Product Portfolio
- 8.1.5 Perfetti Van Melle (Halls) Recent Developments
- 8.2 Reckitt Benckiser (Strepsils)
- 8.2.1 Reckitt Benckiser (Strepsils) Company Information
- 8.2.2 Reckitt Benckiser (Strepsils) Business Overview
- 8.2.3 Reckitt Benckiser (Strepsils) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Reckitt Benckiser (Strepsils) Medicated Confectionery Product Portfolio
- 8.2.5 Reckitt Benckiser (Strepsils) Recent Developments
- 8.3 Ricola AG
- 8.3.1 Ricola AG Company Information
- 8.3.2 Ricola AG Business Overview
- 8.3.3 Ricola AG Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ricola AG Medicated Confectionery Product Portfolio
- 8.3.5 Ricola AG Recent Developments
- 8.4 Jakemans
- 8.4.1 Jakemans Company Information
- 8.4.2 Jakemans Business Overview
- 8.4.3 Jakemans Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Jakemans Medicated Confectionery Product Portfolio
- 8.4.5 Jakemans Recent Developments
- 8.5 Wrigley Company
- 8.5.1 Wrigley Company Company Information
- 8.5.2 Wrigley Company Business Overview
- 8.5.3 Wrigley Company Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Wrigley Company Medicated Confectionery Product Portfolio
- 8.5.5 Wrigley Company Recent Developments
- 8.6 Mondelez International (Ernest Jackson)
- 8.6.1 Mondelez International (Ernest Jackson) Company Information
- 8.6.2 Mondelez International (Ernest Jackson) Business Overview
- 8.6.3 Mondelez International (Ernest Jackson) Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mondelez International (Ernest Jackson) Medicated Confectionery Product Portfolio
- 8.6.5 Mondelez International (Ernest Jackson) Recent Developments
- 8.7 Nestle
- 8.7.1 Nestle Company Information
- 8.7.2 Nestle Business Overview
- 8.7.3 Nestle Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nestle Medicated Confectionery Product Portfolio
- 8.7.5 Nestle Recent Developments
- 8.8 Procter & Gamble
- 8.8.1 Procter & Gamble Company Information
- 8.8.2 Procter & Gamble Business Overview
- 8.8.3 Procter & Gamble Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Procter & Gamble Medicated Confectionery Product Portfolio
- 8.8.5 Procter & Gamble Recent Developments
- 8.9 Meda Pharmaceuticals
- 8.9.1 Meda Pharmaceuticals Company Information
- 8.9.2 Meda Pharmaceuticals Business Overview
- 8.9.3 Meda Pharmaceuticals Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Meda Pharmaceuticals Medicated Confectionery Product Portfolio
- 8.9.5 Meda Pharmaceuticals Recent Developments
- 8.10 UHA Mikakuto
- 8.10.1 UHA Mikakuto Company Information
- 8.10.2 UHA Mikakuto Business Overview
- 8.10.3 UHA Mikakuto Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 UHA Mikakuto Medicated Confectionery Product Portfolio
- 8.10.5 UHA Mikakuto Recent Developments
- 8.11 Herbion International
- 8.11.1 Herbion International Company Information
- 8.11.2 Herbion International Business Overview
- 8.11.3 Herbion International Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Herbion International Medicated Confectionery Product Portfolio
- 8.11.5 Herbion International Recent Developments
- 8.12 HEXOS
- 8.12.1 HEXOS Company Information
- 8.12.2 HEXOS Business Overview
- 8.12.3 HEXOS Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 HEXOS Medicated Confectionery Product Portfolio
- 8.12.5 HEXOS Recent Developments
- 8.13 Lofthouse of Fleetwood
- 8.13.1 Lofthouse of Fleetwood Company Information
- 8.13.2 Lofthouse of Fleetwood Business Overview
- 8.13.3 Lofthouse of Fleetwood Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Lofthouse of Fleetwood Medicated Confectionery Product Portfolio
- 8.13.5 Lofthouse of Fleetwood Recent Developments
- 8.14 Läkerol
- 8.14.1 Läkerol Company Information
- 8.14.2 Läkerol Business Overview
- 8.14.3 Läkerol Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Läkerol Medicated Confectionery Product Portfolio
- 8.14.5 Läkerol Recent Developments
- 8.15 Luden's
- 8.15.1 Luden's Company Information
- 8.15.2 Luden's Business Overview
- 8.15.3 Luden's Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Luden's Medicated Confectionery Product Portfolio
- 8.15.5 Luden's Recent Developments
- 8.16 Olbas
- 8.16.1 Olbas Company Information
- 8.16.2 Olbas Business Overview
- 8.16.3 Olbas Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Olbas Medicated Confectionery Product Portfolio
- 8.16.5 Olbas Recent Developments
- 8.17 Baker Perkins Limited
- 8.17.1 Baker Perkins Limited Company Information
- 8.17.2 Baker Perkins Limited Business Overview
- 8.17.3 Baker Perkins Limited Medicated Confectionery Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Baker Perkins Limited Medicated Confectionery Product Portfolio
- 8.17.5 Baker Perkins Limited Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medicated Confectionery Value Chain Analysis
- 9.1.1 Medicated Confectionery Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medicated Confectionery Production Mode & Process
- 9.2 Medicated Confectionery Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medicated Confectionery Distributors
- 9.2.3 Medicated Confectionery Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst